Patient preferences for long-acting HIV treatment: a preference heterogeneity assessment.

ABSTRACT:

Background

Long-acting antiretroviral therapy (LA-ART) is an emerging alternative to daily oral ART pills that may improve HIV treatment adherence. We studied preference heterogeneity for LA-ART among people with HIV (PWH) in western Washington State and Atlanta, Georgia to determine how preference heterogeneity was related to individual characteristics.

Methods

We recruited 699 PWH to complete a survey including 17 choice-tasks, each of which included two hypothetical LA-ART alternatives and current daily oral therapy. Each hypothetical alternative was defined by mode (long-acting [LA] oral pills, subcutaneous injections, intramuscular injections, and implants), frequency, treatment location (home, clinic, or pharmacy), injection pain, pre-treatment time undetectable, pre-t

SUBMITTER: Saldarriaga EM 

PROVIDER: S-EPMC11841254 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature